Venture Visionary Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,195
Closed -$85K 764
2026
Q1
$85K Sell
14,195
-17,861
-56% -$134K ﹤0.01% 615
2025
Q4
$230K Buy
32,056
+11,207
+54% +$88.5K 0.01% 577
2025
Q3
$223K Buy
20,849
+1,616
+8% +$15.9K 0.01% 573
2025
Q2
$186K Buy
+19,233
New +$198K 0.01% 570
2024
Q3
Sell
-10,857
Closed -$225K 573
2024
Q2
$225K Buy
+10,857
New +$216K 0.01% 505
2023
Q4
Sell
-58,097
Closed -$1.01M 553
2023
Q3
$1.01M Buy
58,097
+4,186
+8% +$87.3K 0.06% 245
2023
Q2
$1.12M Buy
+53,911
New +$1.17M 0.07% 226
2022
Q3
Sell
-3,721
Closed -$126K 1197
2022
Q2
$126K Buy
+3,721
New +$130K 0.01% 549
2022
Q1
Sell
-6,715
Closed -$204K 528
2021
Q4
$204K Sell
6,715
-164
-2% -$5.34K 0.01% 489
2021
Q3
$225K Buy
6,879
+85
+1% +$2.72K 0.02% 462
2021
Q2
$205K Buy
+6,794
New +$224K 0.02% 472

Other funds holding OGN

Venture Visionary Partners's OGN Position: Q2 2026 in Review

Venture Visionary Partners sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 14,195 shares — an estimated $85K sold.

Venture Visionary Partners first reported a position in OGN in Q2 2021 and held it in 11 quarters. The position peaked at $1.12M in Q2 2023. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Venture Visionary Partners reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Venture Visionary Partners sold 14,195 Organon & Co shares in Q2 2026, an estimated $85K.
  • Venture Visionary Partners first reported a position in Organon & Co in Q2 2021 and held it in 11 quarters.
  • Venture Visionary Partners's Organon & Co position peaked at $1.12M in Q2 2023.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.